AstraZeneca Return On Tangible Equity 2010-2024 | AZN

AstraZeneca return on tangible equity for the quarter ending September 30, 2024 was -32.11.

  • AstraZeneca average return on tangible equity for 2023 was -25.75, a 733.33% increase from 2022.
  • AstraZeneca average return on tangible equity for 2022 was -3.09, a 76.39% increase from 2021.
  • AstraZeneca average return on tangible equity for 2021 was -13.09, a 2.83% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

AstraZeneca Return On Tangible Equity 2010-2024 | AZN

  • AstraZeneca average return on tangible equity for 2023 was -25.75, a 733.33% increase from 2022.
  • AstraZeneca average return on tangible equity for 2022 was -3.09, a 76.39% increase from 2021.
  • AstraZeneca average return on tangible equity for 2021 was -13.09, a 2.83% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.